Volume 25, Issue 3, Pages (March 2017)

Slides:



Advertisements
Similar presentations
Molecular Therapy - Methods & Clinical Development
Advertisements

Lentiviral gene transfer and ex vivo expansion of human primitive stem cells capable of primary, secondary, and tertiary multilineage repopulation in NOD/SCID.
Comparative clonal analysis of reconstitution kinetics after transplantation of hematopoietic stem cells gene marked with a lentiviral SIN or a γ-retroviral.
Effective reduction of the interleukin-1β transcript in osteoarthritis-prone guinea pig chondrocytes via short hairpin RNA mediated RNA interference influences.
Volume 26, Issue 1, Pages (January 2018)
Volume 25, Issue 9, Pages (September 2017)
Molecular Therapy - Methods & Clinical Development
Stable in vivo expression of glucose-6-phosphate dehydrogenase (G6PD) and rescue of G6PD deficiency in stem cells by gene transfer by Ana Rovira, Maria.
Correction of a mouse model of sickle cell disease: lentiviral/antisickling β-globin gene transduction of unmobilized, purified hematopoietic stem cells.
Volume 140, Issue 1, Pages (January 2011)
Therapeutic levels of fetal hemoglobin in erythroid progeny of β-thalassemic CD34+ cells after lentiviral vector-mediated gene transfer by Andrew Wilber,
Volume 17, Issue 8, Pages (August 2009)
Volume 15, Issue 1, Pages (January 2007)
Volume 12, Issue 6, Pages (December 2005)
Volume 10, Issue 3, Pages (September 2004)
Volume 6, Issue 5, Pages (November 2009)
Neeltje A Kootstra, Ryusuke Matsumura, Inder M Verma  Molecular Therapy 
Volume 20, Issue 5, Pages (May 2012)
Volume 11, Issue 4, Pages (April 2005)
Volume 13, Issue 6, Pages (June 2006)
Volume 23, Issue 5, Pages (May 2015)
Selective Purging of Human Multiple Myeloma Cells from Autologous Stem Cell Transplantation Grafts using Oncolytic Myxoma Virus  Eric Bartee, Winnie M.
Molecular Therapy - Methods & Clinical Development
Volume 28, Issue 2, Pages (August 2015)
Volume 12, Issue 6, Pages (December 2005)
Volume 12, Issue 3, Pages (September 2005)
Volume 4, Issue 2, Pages (February 2003)
Vaccinia virus as a subhelper for AAV replication and packaging
Volume 25, Issue 9, Pages (September 2017)
Molecular Therapy - Methods & Clinical Development
Disruption of the BCL11A Erythroid Enhancer Reactivates Fetal Hemoglobin in Erythroid Cells of Patients with β-Thalassemia Major  Nikoletta Psatha, Andreas.
The Competitive Nature of HOXB4-Transduced HSC Is Limited by PBX1
Jun Zhan, Irudayam Maria Johnson, Matthew Wielgosz, Arthur W Nienhuis 
Volume 25, Issue 8, Pages (August 2017)
Molecular Therapy - Methods & Clinical Development
Volume 11, Issue 3, Pages (September 2018)
Volume 20, Issue 10, Pages (October 2012)
Volume 19, Issue 3, Pages (March 2011)
Ravindra Majeti, Christopher Y. Park, Irving L. Weissman 
Volume 10, Issue 3, Pages (March 2018)
Molecular Therapy - Methods & Clinical Development
J.P O'Rourke, H Hiraragi, K Urban, M Patel, J.C Olsen, B.A Bunnell 
Volume 23, Issue 1, Pages (January 2015)
Volume 4, Issue 2, Pages (February 2009)
Volume 3, Issue 1, Pages (January 2001)
Volume 9, Issue 4, Pages (October 2017)
Volume 6, Issue 5, Pages (November 2002)
Volume 8, Issue 6, Pages (December 2003)
Volume 15, Issue 8, Pages (August 2007)
Volume 15, Issue 4, Pages (April 2007)
Morvarid Moayeri, Teresa S. Hawley, Robert G. Hawley  Molecular Therapy 
Volume 22, Issue 4, Pages (April 2014)
Volume 11, Issue 6, Pages (June 2005)
Volume 18, Issue 4, Pages (April 2010)
Tobias Maetzig, Jens Ruschmann, Lea Sanchez Milde, Courteney K
Volume 25, Issue 11, Pages (November 2017)
Volume 17, Issue 5, Pages (May 2009)
Volume 17, Issue 1, Pages (January 2009)
Volume 17, Issue 4, Pages (October 2015)
Molecular Therapy - Nucleic Acids
Triplex-forming Peptide Nucleic Acids Induce Heritable Elevations in Gamma-globin Expression in Hematopoietic Progenitor Cells  Joanna Y Chin, Faisal.
Volume 21, Issue 1, Pages (January 2013)
Volume 3, Issue 4, Pages (April 2001)
Pre-clinical Development of a Lentiviral Vector Expressing the Anti-sickling βAS3 Globin for Gene Therapy for Sickle Cell Disease  Valentina Poletti,
Volume 33, Issue 1, Pages (July 2010)
Volume 17, Issue 6, Pages (June 2009)
Volume 20, Issue 11, Pages (November 2012)
Volume 15, Issue 10, Pages (October 2007)
Volume 17, Issue 2, Pages (February 2009)
Carsten T. Charlesworth, Joab Camarena, M
Presentation transcript:

Volume 25, Issue 3, Pages 593-605 (March 2017) Lentiviral Transfer of γ-Globin with Fusion Gene NUP98-HOXA10HD Expands Hematopoietic Stem Cells and Ameliorates Murine β-Thalassemia  Hui Fen Zhao, Allistair Abraham, Yoon-Sang Kim, Yong-Dong Wang, Tamara Pestina, Jun Zhan, Keith Humphries, Arthur W. Nienhuis, Derek A. Persons  Molecular Therapy  Volume 25, Issue 3, Pages 593-605 (March 2017) DOI: 10.1016/j.ymthe.2017.01.019 Copyright © 2017 Terms and Conditions

Figure 1 Increased Engraftment of Human CD34+ Cells Transduced with NA10HD in NSG Mice (A) Human nucleated hematopoietic cell engraftment (CD45+) as percentage of total bone marrow harvested from NSG mice 4 months post-transplantation with lentiviral transduced CD34+ cells. n, number of animals. (B) CFU-C assay of human CD45+ engrafted cells were sorted from bone marrow of NSG mice 4 months post-transplantation with lentiviral transduced CD34+ cells. (C) Percentage of positive colonies which were determined to contain an integrated virus fragment by using PCR in CFU-C assay of grafts and engrafts of NSG mice. (D) Fold differences of positivity of CFU-C colonies of the transplant graft versus engrafting cells in NSG mice. (E) Comparison of copy number between mCherry and NA10HD groups. The genomic DNA was derived from sorted CD45+ engrafted cells whose were derived from bone marrow of NSG mice. (F) Distribution of CD19+ and CD15/33+ cells among three groups of CD45+ engrafted cells. Mock n = 5, mCherry n = 8, NA10HD n = 6. Molecular Therapy 2017 25, 593-605DOI: (10.1016/j.ymthe.2017.01.019) Copyright © 2017 Terms and Conditions

Figure 2 Significant Increase of F Cell Percentage and HbF Protein in β-Thalassemic Mice Transplanted with Thalassemic Marrow Transduced with γ-Globin/NA10HD Lentiviral Vector (A) F cell percentage in the γ-globin/NA10HD of 14 mice and the γ-globin/mCherry of 11 mice transduced groups at 3 and 6 months post-transplantation. N, number of mice. (B) Comparison of HbF protein by HPLC between γ-globin/mCherry and γ-globin/NA10HD vector groups at either 3 or 6 months post-transplantation. Statistically significant differences are indicated by p values < 0.05 as determined using Student’s t test. (C) Cellulose acetate gel electrophoresis of RBC lysates derived from individually transplanted animals. Two controls were used in the gels in Figure 2D, BL6 (C57/BL6) and β-Thal, which was from the thalassemic mouse. Top: the animal that received γ-globin/NA10HD vector; bottom: the samples derived from γ-globin/mCherry vector-transduced animals. The HbF protein band is marked by an arrow. Animal identification numbers are shown at the top of the respective gel bands. Molecular Therapy 2017 25, 593-605DOI: (10.1016/j.ymthe.2017.01.019) Copyright © 2017 Terms and Conditions

Figure 3 Higher Hemoglobin Level in γ-Globin/NA10HD Lentiviral Vector Group Compared with Both γ-globin/mCherry and Mock Control Groups (A) Comparison of the Hb levels among γ-globin/NA10HD, γ-globin/mCherry and Mock groups in blood collected 6 months post-transplantation. Statistically significant differences are indicated by p values < 0.05, as determined by Student’s t test. (B) Correlation between Hb level and RBC count in γ-globin/NA10HD-transduced group. (C) Correlation between Hb level and RBC in γ-globin/mCherry control group. (D) Blood smear slides stained by Giemsa method were derived from γ-globin/NA10HD, γ-globin/mCherry-transduced β-thalassemic cells, and mock control 3 months post-transplantation. Molecular Therapy 2017 25, 593-605DOI: (10.1016/j.ymthe.2017.01.019) Copyright © 2017 Terms and Conditions

Figure 4 Correlation between White Blood Cell Count and Hemoglobin Level in Mice That Had Correction of Anemia (A) Comparison of white blood cell count among γ-globin/NA10HD, γ-globin/mCherry, and Mock groups. The p value is indicated on each graph. (B) Correlation of hemoglobin level and total WBC count derived from β-thalassemic mice transplanted 6 months prior using γ-globin/NA10HD-transduced marrow (p = 0.0345). (C) Comparison of WBC count between 3 and 6 month post-transplantation time points of γ-globin/NA10HD and 6 months of experiment 2 using the same vector but with 50% MOI and labeled as NA10HD2. (D) Correlation of hemoglobin level and WBC count from β-thalassemic mice 6 months post-transplantation in experiment 2 using lower MOI γ-globin/NA10HD vector (p = 0.7209). The linear regression lines and 95% confidence band interval were plotted with data from the γ-globin/NA10HD and NA10HD2 groups. Molecular Therapy 2017 25, 593-605DOI: (10.1016/j.ymthe.2017.01.019) Copyright © 2017 Terms and Conditions

Figure 5 Vector Copy Numbers Correlate with Hemoglobin Level and the Counts of RBCs and WBCs in Thalassemic Mice Transplanted with γ-Globin/NA10HD Expressing Lentivirus (A) Schematic diagram of the γ-globin/NA10HD lentiviral vector indicating the restriction enzyme sites used for Southern blot analysis. (B) Analysis of genomic DNA pattern of mice in γ-globin/NA10HD group as measured by Southern blot analysis. The DNA was digested using BglII, and the size of the DNA band is indicated by arrow. The copy number of each lane represents the vector copy number quantified by densitometry relative to the “standard one-copy”; a K562 clone containing a single copy of an integrated GFP lentiviral vector was used as the “standard one-copy” reference. (C–E) Correlations of copy number of individual animals of the γ-globin/NA10HD lentiviral vector with Hb level (C), RBC count (D), and WBC count (E). Molecular Therapy 2017 25, 593-605DOI: (10.1016/j.ymthe.2017.01.019) Copyright © 2017 Terms and Conditions

Figure 6 Hb Level in the γ-Globin/NA10HD Group Is Preserved in Secondary Transplanted Animals (A) Comparison of Hb level in the γ-globin/NA10HD group from primary (n = 14) and secondary (n = 23) transplanted animals. (B) Correlation of Hb level and RBC count in the γ-globin/NA10HD group. (C) Comparison of WBC count between primary and secondary transplant of the γ-globin/NA10HD groups. (D) Correlation of Hb level and WBC count in γ-globin/NA10HD group. Molecular Therapy 2017 25, 593-605DOI: (10.1016/j.ymthe.2017.01.019) Copyright © 2017 Terms and Conditions

Figure 7 Profile of the Virus Integration Site in Mouse Bone Marrow Genomic DNA after Transduction with the γ-Globin/NA10HD Vector (A) The locations of 715 virus integration sites related to the gene: the percentages of total integration sites within 20 kb upstream of transcript start sites, within genes, and within 50 kb of oncogenes or tumor suppressor genes were plotted against three size-matched sets of computer-generated random sites. (B) Ontologies of genes within 50 kb of integration sites compared with size-matched set of genes within 50 kb of random generated sites, using the DAVID functional annotation tool. Molecular Therapy 2017 25, 593-605DOI: (10.1016/j.ymthe.2017.01.019) Copyright © 2017 Terms and Conditions